Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Diabetes

Date Submitted: Aug 27, 2021
Date Accepted: Mar 24, 2022
Date Submitted to PubMed: Apr 18, 2022

The final, peer-reviewed published version of this preprint can be found here:

GoFundMe as a Medical Plan: Ecological Study of Crowdfunding Insulin Success

Blanchette JE, Tran M, Grigorian EG, Iacob E, Edelman LS, Oser TK, Litchman ML

GoFundMe as a Medical Plan: Ecological Study of Crowdfunding Insulin Success

JMIR Diabetes 2022;7(2):e33205

DOI: 10.2196/33205

PMID: 35436214

PMCID: 9055489

GoFundMe isn't a Medical Plan: An Ecological Study of Crowdfunding Insulin Success

  • Julia E Blanchette; 
  • M.J. Tran; 
  • Ernest G Grigorian; 
  • Eli Iacob; 
  • Linda S Edelman; 
  • Tamara K Oser; 
  • Michelle L Litchman

ABSTRACT

Background:

Individuals in need of medical care are turning to crowdfunding websites to engage a 'crowd' or group for financial support. In the last decade, access to insulin has decreased considerably for several reasons, including the rising cost of insulin, high-deductible insurance plans and increasing insurance premiums. Many people with diabetes are forced to ration or go without insulin, and are turning to crowdfunding websites to seek financial donations to purchase insulin needed to reduce health risks and mortality, and sustain quality of life. This study aims to explore crowdfunding campaign requests to purchase insulin in the United States.

Objective:

To explore crowdfunding campaign requests to purchase insulin in the United States.

Methods:

In this retrospective, mixed-methods study, we coded the text of “GoFundMe” online crowdfunding campaigns and viral measures (shares, hearts and comments) from February 25 to April 15, 2019. We described campaigns (N = 205) and explored factors associated with campaign success using correlations and qualitative thematic analysis.

Results:

The majority of campaigns were initiated by middle-aged adults (26-64-years) (N = 77, 37.6%), with type 1 diabetes (N = 94, 45.9%) needing funds due to insurance coverage issues (N = 125, 61.0%). Factors associated with campaign success included requests for <$500 (P < .01), and higher viral measures (shares, P = .007; hearts, P < .001; comments, P = .002). Four themes emerged from the campaign text: 1) desire for self-management and survival, 2) diabetes management untenable given insulin access, 3) the aftermath of insulin unaffordability, and 4) privacy issues with crowdfunding. Campaign comments were both supportive (tangible, informational, emotional) and unsupportive (questioned need for campaign, crowdfunding deemed inappropriate).

Conclusions:

Despite crowdfunding websites being used to support the purchase of insulin, campaigns raise only a fraction of the money requested. Therefore, “GoFundMe” Campaigns are not a reliable solution to obtaining insulin funds in the United States. Applying mixed-methods is effective to analyze online crowdfunding for medication costs such as insulin. However, it is critical for PWD to use resources other than online crowdfunding to access and obtain insulin due to low success rates.


 Citation

Please cite as:

Blanchette JE, Tran M, Grigorian EG, Iacob E, Edelman LS, Oser TK, Litchman ML

GoFundMe as a Medical Plan: Ecological Study of Crowdfunding Insulin Success

JMIR Diabetes 2022;7(2):e33205

DOI: 10.2196/33205

PMID: 35436214

PMCID: 9055489

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.